Statement re press speculation

Source: RNS
RNS Number : 2189O
IP Group PLC
30 January 2023
 

FOR RELEASE ON

30 January 2023

 

IP Group plc - Statement re press speculation

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses, notes the press speculation regarding portfolio company Istesso Ltd. The Group is aware of exploratory discussions around a potential business combination which have now been terminated.

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications           

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Numis


James Black

+44 (0) 20 7260 1000

Portland


Vic Wallin

+44 (0) 7973 823 119 

Alex Donaldson

+44 (0) 7516 729 702

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCNKKBNKBKKFDN